Biofrontera Inc. Increase (Decrease) in Other Accrued Liabilities
Biofrontera Inc. (BFRI) reported Increase (Decrease) in Other Accrued Liabilities of $274.00 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2023-10-03
- Biofrontera Inc. increase (decrease) in other accrued liabilities for the quarter ending 2023-03-31 was $274.00K.
- Biofrontera Inc. increase (decrease) in other accrued liabilities for the quarter ending 2022-12-31 was -$3.39M, a 519.68% decline year-over-year.
- Biofrontera Inc. increase (decrease) in other accrued liabilities for the quarter ending 2022-09-30 was $24.00K, a 99.79% decline year-over-year.
- Biofrontera Inc. increase (decrease) in other accrued liabilities for the quarter ending 2022-06-30 was $867.00K.
- Biofrontera Inc. increase (decrease) in other accrued liabilities for fiscal 2020 was -$685.00K.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2023-03-31 | $274.00K 10-Q · filed 2023-05-12 | -$3.12M derived: sum of 2 quarters · filed 2023-10-03 | -$3.09M derived: sum of 3 quarters · filed 2023-10-03 | -$2.23M derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-12-31 | -$3.39M derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | -$3.37M derived: sum of 2 quarters · filed 2023-10-03 | -$2.50M derived: sum of 3 quarters · filed 2023-10-03 | -$3.61M 8-K · filed 2023-10-03 |
| 2022-09-30 | $24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $891.00K derived: sum of 2 quarters · filed 2022-11-14 | -$216.00K 10-Q · filed 2022-11-14 | $592.00K derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-06-30 | $867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$240.00K 10-Q · filed 2022-08-12 | $568.00K derived: sum of 3 quarters · filed 2023-10-03 | $12.09M derived: sum of 4 quarters · filed 2023-10-03 |
| 2022-03-31 | -$1.11M 10-Q · filed 2023-05-12 | -$299.00K derived: sum of 2 quarters · filed 2023-10-03 | $11.22M derived: sum of 3 quarters · filed 2023-10-03 | $11.18M derived: sum of 4 quarters · filed 2023-10-03 |
| 2021-12-31 | $808.00K derived: 8-K 12 month − 10-Q 9 month · filed 2023-10-03 | $12.33M derived: sum of 2 quarters · filed 2023-10-03 | $12.29M derived: sum of 3 quarters · filed 2023-10-03 | $12.48M 8-K · filed 2023-10-03 |
| 2021-09-30 | $11.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $11.48M derived: sum of 2 quarters · filed 2022-11-14 | $11.68M 10-Q · filed 2022-11-14 | $11.44M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $152.00K 10-Q · filed 2022-08-12 | -$85.00K derived: sum of 3 quarters · filed 2022-08-12 | |
| 2021-03-31 | $193.00K 10-Q · filed 2022-05-13 | -$44.00K derived: sum of 2 quarters · filed 2022-05-13 | ||
| 2020-12-31 | -$237.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-11 | -$685.00K 10-K · filed 2022-04-11 | ||
| 2020-09-30 | -$448.00K 10-Q · filed 2021-11-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |